Effect of oral sirolimus therapy on inflammatory biomarkers following coronary stenting

Effect of oral sirolimus therapy on inflammatory biomarkers following coronary stenting

Autor Rosa, Werther Clay Monico Autor UNIFESP Google Scholar
Campos, Alexandre Holthausen Autor UNIFESP Google Scholar
Lima, Valter Correia Autor UNIFESP Google Scholar
Instituição Universidade Federal de São Paulo (UNIFESP)
Universidade Federal do Espírito Santo Hospital Universitário Cassiano Antonio de Morais Disciplina de Cardiologia
Resumo We studied the effect of oral sirolimus, administered to prevent and treat in-stent restenosis (ISR), on the variation of serum levels of inflammatory markers following coronary stenting with bare metal stents. The mean age of the patients was 56 ± 13 years, 65% were males and all had clinically manifested ischemia. Serum levels of high sensitivity C-reactive protein (hs-CRP) concentration were determined by chemiluminescence and serum levels of all other biomarkers by ELISA. One group of patients at high risk for ISR received a loading oral dose of 15 mg sirolimus and 5 mg daily thereafter for 28 days after stenting (SIR-G). A control group (CONT-G) was submitted to stenting without sirolimus therapy. The increase in hs-CRP concentration was highest at 24 h after stenting in both groups. A significant difference between SIR-G and CONT-G was observed at 4 weeks (-1.50 ± 5.0 vs -0.19 ± 0.4, P = 0.008) and lost significance 1 month after sirolimus discontinuation (-1.73 ± 4.3 vs -0.01 ± 0.7, P = 0.0975). A continuous fall in MMP-9 concentration was observed in SIR-G, with the greatest reduction at 4 weeks (-352.9 ± 455 vs +395.2 ± 377, P = 0.0004), while a positive variation was noted 4 weeks after sirolimus discontinuation (227 ± 708 vs 406.2 ± 472.1, P = 0.0958). SIR-G exhibited a higher increase in P-selectin after sirolimus discontinuation at week 8 (46.1 ± 67.9 vs 5.8 ± 23.7, P = 0.0025). These findings suggest that the anti-restenotic actions of systemic sirolimus include anti-proliferative effects and modulation of the inflammatory response with inhibition of adhesion molecule expression.
Palavra-chave Inflammation mediators
Oral sirolimus
Percutaneous coronary intervention
Coronary artery angioplasty
Coronary restenosis
Immunosuppression
Idioma Inglês
Financiador Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Número do financiamento FAPESP: 03/02946-7
Data de publicação 2010-08-01
Publicado em Brazilian Journal of Medical and Biological Research. Associação Brasileira de Divulgação Científica, v. 43, n. 8, p. 786-793, 2010.
ISSN 0100-879X (Sherpa/Romeo, fator de impacto)
Publicador Associação Brasileira de Divulgação Científica
Extensão 786-793
Fonte http://dx.doi.org/10.1590/S0100-879X2010007500071
Direito de acesso Acesso aberto Open Access
Tipo Artigo
Web of Science WOS:000283261800012
SciELO S0100-879X2010000800012 (estatísticas na SciELO)
Endereço permanente http://repositorio.unifesp.br/handle/11600/5879

Exibir registro completo




Arquivo

Nome: S0100-879X2010000800012.pdf
Tamanho: 450.2KB
Formato: PDF
Descrição:
Abrir arquivo

Este item está nas seguintes coleções

Buscar


Navegar

Minha conta